Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Prove is the modern way of proving identity with just a phone number. With 1 billion+ consumer and small business identity tokens under continuous management, Prove’s Phone-Centric Identity™ platform helps healthcare, payor, retail, and technology organizations provide frictionless consumer engagement across digital portals, mobile apps, and contact centers. In addition to verification and authentication, Prove&#39;s platform supports outbound engagement by discovering consumer phone numbers and automatically updating phone numbers as consumers change them.

Prove - HLTH 2021 Sponsor

Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 90 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. Recently, the Company received 510(k) clearance from the U.S. FDA for its revolutionary office-based MRI system, allowing practices and hospitals to seamlessly guide prostate interventions under the single-sided scanner. Promaxo has formed numerous long-term and strategic partnerships with investor groups and corporations as it prepares to enter the US market.

Promaxo - HLTH 2021 Sponsor

At Propeller Health, our mission is to empower every person living with a chronic respiratory disease to take control of their health so they can live a better life. As a leader in digital health and therapeutics for asthma and COPD, we work to improve clinical outcomes, healthcare costs, and quality of life by supporting patients in managing their condition with their healthcare provider.

Propeller’s platform includes FDA cleared medical devices, consumer apps and access to clinical data for provider monitoring throughout the care journey, to create value to all stakeholders. We enable a personalized digital experience with a human touch used by patients, caregivers, providers, payers, pharmaceutical companies and other healthcare organizations across the US, Europe and Asia.

Propeller Health is a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD). For more information, visit www.propellerhealth.com.

Propeller Health - HLTH 2021 Sponsor